These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 22246609)
1. Salivary gland cancers: biology and molecular targets for therapy. Bell D; Hanna EY Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609 [TBL] [Abstract][Full Text] [Related]
2. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences. Stenman G Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214 [TBL] [Abstract][Full Text] [Related]
3. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"]. Skálová A; Šteiner P; Vaneček T Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014 [TBL] [Abstract][Full Text] [Related]
4. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma. Bhaijee F; Pepper DJ; Pitman KT; Bell D Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915 [TBL] [Abstract][Full Text] [Related]
5. Translocation-associated salivary gland tumors: a review and update. Weinreb I Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307 [TBL] [Abstract][Full Text] [Related]
6. [A new analysis tool of salivary gland tumors: looking for specific translocations]. Uro-Coste E Ann Pathol; 2011 Nov; 31(5 Suppl):S100-2. PubMed ID: 22054439 [No Abstract] [Full Text] [Related]
7. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319 [TBL] [Abstract][Full Text] [Related]
8. Salivary gland cancer: an update on present and emerging therapies. Carlson J; Licitra L; Locati L; Raben D; Persson F; Stenman G Am Soc Clin Oncol Educ Book; 2013; ():257-63. PubMed ID: 23714518 [TBL] [Abstract][Full Text] [Related]
9. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292 [TBL] [Abstract][Full Text] [Related]
10. [Advances in genetics and pathology of salivary gland tumors]. Gao Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):193-8. PubMed ID: 22800695 [No Abstract] [Full Text] [Related]
11. Salivary gland cancers: current treatments, molecular characteristics and new therapies. Chandana SR; Conley BA Expert Rev Anticancer Ther; 2008 Apr; 8(4):645-52. PubMed ID: 18402531 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas. Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751 [TBL] [Abstract][Full Text] [Related]
13. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104 [TBL] [Abstract][Full Text] [Related]
14. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080 [TBL] [Abstract][Full Text] [Related]
15. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective. Toper MH; Sarioglu S Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400 [TBL] [Abstract][Full Text] [Related]
16. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406 [TBL] [Abstract][Full Text] [Related]
18. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609 [TBL] [Abstract][Full Text] [Related]
19. Clinical implication of CD166 expression in salivary gland tumor. Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586 [TBL] [Abstract][Full Text] [Related]
20. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). Marchiò C; Weigelt B; Reis-Filho JS J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]